Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Poorly differentiated thyroid carcinomas: new therapeutic considerations].

Hans Graf1

  • 1Serviço de Endocrinologia e Metabologia, Universidade Federal do Paraná, Curitiba, PR. hansgraf@bsi.com.br

Arquivos Brasileiros De Endocrinologia E Metabologia
|January 31, 2006
PubMed
Summary

Differentiated thyroid cancers are treated with surgery, radioactive iodine, and hormone therapy. Targeted therapies offer new hope for managing advanced or poorly differentiated thyroid carcinomas that resist standard treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Differences in the aggressiveness of familial versus sporadic non-medullary thyroid cancer: An unresolved controversy.

Archives of endocrinology and metabolism·2026
Same author

The decline of iodine therapy in the treatment of Graves' disease in a hospital center: a 20-year analysis.

Archives of endocrinology and metabolism·2026
Same author

Interventions to Reduce Skin-related Self-stigma: A Systematic Review.

Acta dermato-venereologica·2024
Same author

Approach to adult patients with primary hypothyroidism in some special situations: a position statement from the Thyroid Department of the Brazilian Society of Endocrinology and Metabolism (SBEM).

Archives of endocrinology and metabolism·2022
Same author

Choosing Wisely for Thyroid Conditions: Recommendations of the Thyroid Department of the Brazilian Society of Endocrinology and Metabolism.

Archives of endocrinology and metabolism·2021
Same author

Is there a place for measuring serum calcitonin prior to thyroidectomy in patients with a non-diagnostic thyroid nodule biopsy?

Archives of endocrinology and metabolism·2021

Area of Science:

  • Oncology
  • Endocrinology
  • Molecular Biology

Context:

  • Differentiated thyroid carcinomas (papillary and follicular) are typically managed with total thyroidectomy, radioactive iodine ((131)I) therapy, and thyroid hormone treatment to suppress TSH.
  • Poorly differentiated thyroid carcinomas lose key functions like iodine uptake and thyrotropin dependence, posing treatment challenges.
  • Advanced follicular cell-derived thyroid cancers that progress despite standard therapies require novel treatment strategies.

Purpose:

  • To review the current challenges in treating advanced and poorly differentiated thyroid carcinomas.
  • To highlight the emerging role of targeted cancer therapies in managing refractory thyroid tumors.
  • To emphasize the potential of combination therapies for improving patient outcomes.

Summary:

Related Experiment Videos

  • Standard treatments for differentiated thyroid cancer include surgery, (131)I ablation, and TSH suppression.
  • Poorly differentiated thyroid carcinomas exhibit reduced iodine uptake and TSH dependence, complicating treatment.
  • Targeted therapies are increasingly used to address abnormal molecular signaling in thyroid cancer cells.
  • Identifying critical molecular pathways is key to developing effective combination therapies for poorly differentiated thyroid carcinoma.

Impact:

  • Advances in understanding molecular signaling pathways are enabling the development of targeted therapies.
  • Combination therapies targeting multiple molecular requirements show promise for improving the treatment of poorly differentiated thyroid carcinoma.
  • This approach aims to enhance cure rates and disease control for patients with advanced thyroid cancer.